NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Q: What does CUSIP N62509109 represent in this 13F holders report?

CUSIP N62509109 is the security identifier for NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share used to aggregate holder disclosures.

Q: How many institutions held NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share in Q4 2024?

130 institutional investors reported NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: N62509109

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Ordinary Shares, nominal value EUR0.12 per share
Total 13F shares: 98,611,632
Total 13F value: $2,534,320,573
Share change: +21,446,730
Put/Call ratio: 160%
SEC-reported price per share: $25.70
Number of holders: 130
Value change: +$569,548,998
Number of buys: 82
Number of sells: 47
Shares outstanding: 119,818,667

Security key

N62509109

Report period

Q4 2024

Institutions

130

Top holders

NAMS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 NewAmsterdam Pharma Co N.V. SEC filings NewAmsterdam Pharma Co N.V. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP N62509109

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ForGrowth NAP B.V.

Disclosed value leader

ForGrowth NAP B.V.

Comparable rows

0/15

Latest evidence

30 Dec 2024

3/4/5 13F Highest disclosed value: $272,125,599 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ForGrowth NAP B.V. has the largest disclosed position value at $272.13M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ForGrowth NAP B.V.'s linked filing trail.

Disclosed position value Top 5

ForGrowth NAP B.V. $272.13M

Bain Capital Life Sciences Invest... $239M

Frazier Life Sciences Management,... $216.9M

FCPM III SERVICES B.V. $196.4M

RA CAPITAL MANAGEMENT, L.P. $136.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ForGrowth NAP B.V.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$272,125,599 10,656,172 shares	—	30 Dec 2024
Bain Capital Life Sciences Investors, LLC	3/4/5 13F 10%+ Owner · Company 3/4/5 13F	— mixed-class rows	$239,004,182 12,106,566 shares mixed-class rows	—	13 Dec 2024
Frazier Life Sciences Management, L.P.	13F Company 13F	— mixed-class rows	$216,898,551 13,355,527 shares mixed-class rows	—	30 Sep 2024
FCPM III SERVICES B.V.	13F Company 13F	— denominator unverified	$196,402,253 11,831,461 shares	—	30 Sep 2024
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	— mixed-class rows	$136,195,731 8,397,333 shares mixed-class rows	—	30 Sep 2024
VIKING GLOBAL INVESTORS LP	13F Company 13F	— denominator unverified	$133,207,779 8,024,565 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

130

98,611,632

Rows available

130

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

100

Q4 2024 holders

130

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend